Group One Trading’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-19,953
| Closed | -$668K | – | 8420 |
|
|
2026
Q1 | $668K | Sell |
19,953
-2,577
| -11% | -$101K | ﹤0.01% | 3072 |
|
|
2025
Q4 | $1.04M | Buy |
22,530
+14,134
| +168% | +$775K | ﹤0.01% | 2845 |
|
|
2025
Q3 | $568K | Buy |
+8,396
| New | +$622K | ﹤0.01% | 3577 |
|
|
2024
Q3 | – | Sell |
-37
| Closed | -$1.77K | – | 7305 |
|
|
2024
Q2 | $1.51K | Hold |
37
| – | – | ﹤0.01% | 6281 |
|
|
2024
Q1 | $1.58K | Hold |
37
| – | – | ﹤0.01% | 6536 |
|
|
2023
Q4 | $1.49K | Hold |
37
| – | – | ﹤0.01% | 6903 |
|
|
2023
Q3 | $1.09K | Hold |
37
| – | – | ﹤0.01% | 7202 |
|
|
2023
Q2 | $159 | Hold |
37
| – | – | ﹤0.01% | 7485 |
|
|
2023
Q1 | $79 | Sell |
37
-206
| -85% | -$463 | ﹤0.01% | 7043 |
|
|
2022
Q4 | $481 | Sell |
243
-115
| -32% | -$143 | ﹤0.01% | 6952 |
|
|
2022
Q3 | $1K | Sell |
358
-1
| -0.3% | -$2 | ﹤0.01% | 7377 |
|
|
2022
Q2 | $1K | Sell |
359
-311
| -46% | -$861 | ﹤0.01% | 7618 |
|
|
2022
Q1 | $2K | Sell |
670
-2,259
| -77% | -$11.7K | ﹤0.01% | 7748 |
|
|
2021
Q4 | $18K | Buy |
2,929
+2,060
| +237% | +$21.6K | ﹤0.01% | 7042 |
|
|
2021
Q3 | $12K | Sell |
869
-353
| -29% | -$4.92K | ﹤0.01% | 7432 |
|
|
2021
Q2 | $21K | Buy |
1,222
+811
| +197% | +$13.7K | ﹤0.01% | 7161 |
|
|
2021
Q1 | $8K | Sell |
411
-115
| -22% | -$3.71K | ﹤0.01% | 7129 |
|
|
2020
Q4 | $15K | Sell |
526
-463
| -47% | -$13.4K | ﹤0.01% | 5649 |
|
|
2020
Q3 | $37K | Buy |
+989
| New | +$28.9K | ﹤0.01% | 4828 |
|
Group One Trading's SLNO Position: Q2 2026 in Review
Group One Trading sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 19,953 shares — an estimated $668K sold.
Group One Trading first reported a position in SLNO in Q3 2020 and held it in 19 quarters. The position peaked at $1.04M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Group One Trading reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Group One Trading sold 19,953 Soleno Therapeutics shares in Q2 2026, an estimated $668K.
- Group One Trading first reported a position in Soleno Therapeutics in Q3 2020 and held it in 19 quarters.
- Group One Trading's Soleno Therapeutics position peaked at $1.04M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.